Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China

BACKGROUND: Pyrazinamide still may be a useful drug for treatment of rifampin-resistant (RR-TB) or multidrug-resistant tuberculosis (MDR-TB) in China while awaiting scale up of new drugs and regimens including bedaquiline and linezolid. The level of pyrazinamide resistance among MDR-TB patients in C...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Infect Dis
Main Authors: Xia, Hui, van den Hof, Susan, Cobelens, Frank, Zhou, Yang, Zhao, Bing, Wang, Shengfen, Zhao, Yanlin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6947908/
https://ncbi.nlm.nih.gov/pubmed/31910878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-020-4758-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki